Volume 372, Issue 9647, Pages (October 2008)

Slides:



Advertisements
Similar presentations
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.
Advertisements

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)
Volume 370, Issue 9600, Pages (November 2007)
Volume 387, Issue 10037, Pages (June 2016)
Volume 379, Issue 9824, Pages (April 2012)
Volume 357, Issue 9273, Pages (June 2001)
Volume 364, Issue 9440, Pages (September 2004)
Volume 367, Issue 9517, Pages (April 2006)
Volume 357, Issue 9257, Pages (March 2001)
Volume 370, Issue 9601, Pages (November 2007)
Volume 359, Issue 9322, Pages (June 2002)
Pharmacogenetics and future drug development and delivery
Volume 12, Issue 11, Pages (October 2011)
Volume 376, Issue 9734, Pages (July 2010)
Volume 11, Issue 6, Pages (June 2012)
Meta-analysis of randomised controlled trials
Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised.
Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 
Volume 5, Issue 4, Pages (April 2006)
Volume 389, Issue 10076, Pages (April 2017)
Volume 371, Issue 9611, Pages (February 2008)
Volume 376, Issue 9734, Pages (July 2010)
Volume 366, Issue 9482, Pages (July 2005)
Volume 13, Issue 3, Pages (March 2012)
Volume 366, Issue 9486, Pages (August 2005)
Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled.
Volume 388, Issue 10052, Pages (October 2016)
Volume 14, Issue 4, Pages (April 2015)
Volume 12, Issue 9, Pages (September 2013)
Volume 1, Issue 3, Pages (August 2014)
Volume 373, Issue 9677, Pages (May 2009)
Aspirin in the prevention of cancer – Author's reply
Volume 9, Issue 9, Pages (September 2008)
Volume 366, Issue 9482, Pages (July 2005)
Volume 372, Issue 9642, Pages (September 2008)
Peter Rossing, Philip Hougaard, Hans-Henrik Parving 
Volume 9, Issue 10, Pages (October 2008)
Incident diabetes in clinical trials of antihypertensive drugs
Misoprostol for small bowel ulcers in patients with obscure bleeding taking aspirin and non-steroidal anti-inflammatory drugs (MASTERS): a randomised,
Volume 378, Issue 9801, Pages (October 2011)
Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study  Sune F Nielsen, PhD, Prof Børge G Nordestgaard,
Volume 375, Issue 9732, Pages (June 2010)
Volume 379, Issue 9812, Pages (January 2012)
Volume 380, Issue 9849, Pages (October 2012)
Volume 9, Issue 9, Pages (September 2008)
Volume 14, Issue 11, Pages (October 2013)
Volume 381, Issue 9868, Pages (March 2013)
Volume 388, Issue 10056, Pages (October 2016)
Confessions of a journal junkie
Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 
Volume 371, Issue 9627, Pages (May 2008)
Volume 378, Issue 9786, Pages (July 2011)
C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study  Heart Protection.
Volume 377, Issue 9771, Pages (March 2011)
Primary prophylaxis of cryptococcal disease with fluconazole in HIV-positive Ugandan adults: a double-blind, randomised, placebo-controlled trial  Dr.
Department of Error The Lancet Volume 369, Issue 9564, (March 2007)
Low-technology approaches
Prof GJB van Ommen, PhD, E Bakker, PhD, JT den Dunnen, PhD  The Lancet 
Volume 375, Issue 9714, Pages (February 2010)
Volume 361, Issue 9352, Pages (January 2003)
Volume 7, Issue 8, Pages (August 2008)
Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial  Dr David Preiss, PhD, Suzanne M Lloyd,
Volume 11, Issue 1, Pages (January 2010)
Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled.
Volume 376, Issue 9737, Pages (July 2010)
Volume 368, Issue 9541, Pages (September 2006)
Volume 383, Issue 9930, Pages (May 2014)
Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,
Volume 371, Issue 9611, Pages (February 2008)
Volume 18, Issue 6, Pages (June 2019)
Presentation transcript:

Volume 372, Issue 9647, Pages 1385-1393 (October 2008) Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial  Prof Anne Katrin Sjølie, DrSci, Prof Ronald Klein, MD, Prof Massimo Porta, PhD, Prof Trevor Orchard, MB, Prof John Fuller, FRCP, Prof Hans Henrik Parving, DrSci, Prof Rudy Bilous, FRCP, Prof Nish Chaturvedi, MD  The Lancet  Volume 372, Issue 9647, Pages 1385-1393 (October 2008) DOI: 10.1016/S0140-6736(08)61411-7 Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 1 Trial profile The Lancet 2008 372, 1385-1393DOI: (10.1016/S0140-6736(08)61411-7) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 2 Cumulative proportion of patients with progression of retinopathy by treatment allocation The Lancet 2008 372, 1385-1393DOI: (10.1016/S0140-6736(08)61411-7) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 3 Distribution of changes in ETDRS level during study, by treatment group The Lancet 2008 372, 1385-1393DOI: (10.1016/S0140-6736(08)61411-7) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 4 Cumulative proportion of patients with regression of retinopathy, by treatment group The Lancet 2008 372, 1385-1393DOI: (10.1016/S0140-6736(08)61411-7) Copyright © 2008 Elsevier Ltd Terms and Conditions

Figure 5 Cumulative proportion of patients with regression of retinopathy, grouped by retinopathy level at baseline (A) Microaneurysms only. (B) Mild non-proliferative diabetic retinopathy. (C) Moderate to moderately severe retinopathy. The Lancet 2008 372, 1385-1393DOI: (10.1016/S0140-6736(08)61411-7) Copyright © 2008 Elsevier Ltd Terms and Conditions